Corcept Therapeutics Incorporated · NASDAQ:CORT

Robb Gary Charles sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)

Traded Aug 17, 2026 · Filed Aug 18, 2026

On Aug 17, 2026, Robb Gary Charles (Chief Business Officer) sold 10,000 Corcept Therapeutics Incorporated shares at US$116.26 for US$1.16M, leaving 39,716 shares. Filed Aug 18, 2026 (Form 4).

Sold
10,000 shares
Price
US$116.26
Value
US$1.16M
Holding after
39,716 shares (held indirectly)
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 17, 2026Common StockGift12513,426Direct
Aug 17, 2026Common StockSale10,000US$116.2639,716Indirect

Source

View original at SEC

Related